Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
Maharashtra FDA Reviews Responses from Actors on Vimal Elaichi Ad Notices

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Crime

Maharashtra FDA Reviews Responses from Actors on Vimal Elaichi Ad Notices

Analysed 4 Sept 2026·2 sources analysed·Mumbai, India·Crime
Maharashtra FDA Reviews Responses from Actors on Vimal Elaichi Ad NoticesPreviousNext

The Maharashtra Food and Drug Administration (FDA) has received responses from Bollywood actors Tiger Shroff and Ajay Devgn regarding notices about their Vimal Elaichi advertisements, which are under investigation for alleged surrogate advertising linked to the banned Vimal Pan Masala. Shah Rukh Khan's reply is still awaited. The FDA is examining the responses to determine if the ads violate advertising regulations and will decide on further action after completing the probe.

Sentiment
50%
TBN's observations

First-hand measurement across 2 sources

We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (50/100). Lens Score 45/100.

Outlets measured: english, news18. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 2 sources · Published under editorial oversight by The Balanced News
Analysed 4 Sept 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Neutral (50/100)

Sentiment was consistent across outlets (50–50/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

news18 broke this story on 3 Sept, 12:22 pm. Other outlets followed.

3 Sept, 12:22 pm2 sources · 14 h4 Sept, 02:15 am
AI analysis by the TBN Bias Engine · beat methodology byDushyant Deshmukh· Investigative Writer· editorial standards byOjas Kale
← Previous
Bomb Thrown Near Manipur Congress Leader K. Meghachandra's Residence
Next →
Man Arrested for Alleged Desecration Inside Golden Temple Complex
1
news183 Sept, 12:22 pm
Ajay Devgn And Tiger Shroff Reply To FDA Notice Over Vimal Elaichi Ad, SRK's Response Awaited
  • 2
    english4 Sept, 02:15 am
    Vimal Elaichi Controversy: Tiger Shroff, Ajay Devgn Reply To FDA Notice, SRK Yet To Respond
  • Who's involved

    Institutions and figures named across source coverage.

    Government
    Food and Drug Administration of MaharashtraMaharashtra Food and Drug Administration
    Corporate
    Tiger Shroff Productions Limited Liability Partnership

    Story context

    Category
    Crime
    Location
    Mumbai, India
    Sources analysed
    2
    Last analysed
    4 Sept 2026
    Key entities
    Hindi cinemaTiger ShroffAjay DevgnShah Rukh KhanAdvertisingSurrogacyMaharashtraFood and Drug AdministrationIndo-Asian News ServiceMumbaiTukaramIndian Administrative Service